Otto Erik - 10 Feb 2026 SCHEDULE 13G/A Report for Chemomab Therapeutics Ltd. American Depository Shares, each of which represent twenty ordinary shares, no par value (GLTO)

Filing Manager: Otto Erik
Reporting Manager: Otto Erik
Security: Chemomab Therapeutics Ltd. American Depository Shares, each of which represent twenty ordinary shares, no par value
Symbol: GLTO
Shares outstanding: 6,111,111 shares
Disclosed Ownership: 385,000 shares
Ownership: 6.3%
Form type: SCHEDULE 13G/A
Filing time: 10 Feb 2026, 16:43:27 UTC
Date of event: 10 Feb 2026
Previous filing: 11 Aug 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Otto Erik	6.3%	385,000	385,000		Erik Otto	Individual